Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGI-110 and Irinotecan in Previously Treated Metastatic Colorectal Cancer
NCT01896856Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2013
- Primary completion
- Aug 2019
- Modality
- DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of guadecitabine in metastatic colorectal cancer (mCRC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2013; status: completed.
02
Drugs
guadecitabine
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01896856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01896856.